Peptide Profiles

Tesamorelin is a modified full-length GHRH analog with enhanced DPP-4 resistance. Review of preclinical and published research on visceral adipose tissue, hepatic fat, body composition, and cognitive effects.

Sermorelin and CJC-1295 are synthetic GHRH analogs that stimulate growth hormone release through the endogenous pathway. Review of mechanisms, half-life differences, synergy with GHS compounds, and preclinical applications.

MOTS-c is a mitochondrial-derived peptide that activates AMPK and regulates metabolic homeostasis. Review of its discovery, nuclear translocation mechanism, exercise-mimetic properties, and aging research.

PT-141 is a selective melanocortin-4 receptor agonist derived from Melanotan-II research. Review of preclinical evidence on MC4R mechanisms, central nervous system pathways, and reproductive research.

AOD9604 is a synthetic fragment of human growth hormone (amino acids 177-191) studied for selective lipolytic activity without growth-promoting effects. Review of preclinical research on mechanisms and metabolic findings.

NAD+ is a coenzyme central to cellular metabolism, DNA repair, and aging. This review covers the biochemistry, age-related decline, and key preclinical findings from published research.

Epithalon is a synthetic tetrapeptide studied for its effects on telomerase activity, telomere elongation, and aging biomarkers. Review of the peer-reviewed literature from three decades of investigation.

Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without affecting cortisol, prolactin, or ACTH. Review of preclinical research on mechanisms, selectivity, and applications.

TB-500 is a synthetic analog of thymosin beta-4. This research review covers its molecular mechanisms, preclinical evidence in wound healing, cardiac research, and connective tissue models.